Alternative Products Expo (“Alt Pro Expo”), the flagship event series in the global counterculture industry, returns to Georgia at the Atlanta Alt Pro Expo 2024 (“expo”). The upcoming counterculture festival and vape trade show is scheduled for October 10-12, 2024, at the Cobb Galleria Center in Atlanta, Georgia. The expo will showcase an incredible portfolio … Continue reading “CannabisNewsBreaks – Alternative Products Expo, the Counterculture Festival and Vape Trade Show, Returns to Atlanta this October”

Lexaria Bioscience Corp. (NASDAQ: LEXX) recently released its fiscal report for the third quarter of the 2024 financial year (“Q3, 2024”). “Of note was growth in cash and marketable securities from $1.5 million during the same period in the 2023 financial year to $8.5 million as of May 31, 2024. The company reduced certain R&D … Continue reading “CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyeing Market Potential with Unique Delivery Platform, GLP-1 Program”

CannabisNewsWire (“CNW”), a specialized communications platform for the cannabis sector and one of the 65+ brands powered by IBN, on Thursday announced that it has been named the Official NewsWire of the NY Cannabis Insider event, with IBN serving as the Official Media Sponsor. The event, scheduled for September 25, 2024, at The Desmond Hotel … Continue reading “CannabisNewsBreaks – CannabisNewsWire and IBN Partner with NY Cannabis Insider to Boost Visibility for Premier Cannabis Event”

Golden Triangle Ventures (OTC: GTVH), a multifaceted consulting company, today announced a strategic partnership between LE Logistics, LLC, its wholly owned subsidiary, and West End Trucking, Inc. The partnership is expected to significantly boost the company’s asset base and operational capacity and set the stage for continued revenue growth and long-term success. Under the partnership, … Continue reading “CannabisNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Announces Partnership to Boost Operational Capacity, Sustain Revenue Growth in Logistics Division”

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, provided a strategic letter from outgoing CEO Chris Bunka updating all stakeholders. In the strategic update, Bunka discussed Lexaria’s performance in the capital markets; the company’s Phase 1b DehydraTECH-CBD hypertension trial and Australian-registered Phase 1b DehydraTECH-GLP-1 diabetes and weight-loss study; ongoing R&D; and … Continue reading “CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Shares Letter from Outgoing CEO”

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced the appointment of Richard Christopher as the new CEO, effective August 31, 2024. Mr. Christopher is a recognized industry veteran with over three decades of experience in the medical device and pharmaceutical industries. He has domestic and international experience in leadership, … Continue reading “CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Appoints Medical Device and Pharmaceutical Industries Veteran as New CEO”

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, has entered into a Materials Transfer Agreement with a pharmaceutical company. Under the terms of the agreement, the pharmaceutical company will evaluate Lexaria’s DehydraTECH(TM) technology in a pre-clinical setting. Lexaria will be responsible for formulating and supplying certain DehydraTECH compositions, with the pharmaceutical … Continue reading “CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Material Transfer Agreement to Evaluate DehydraTECH(TM) Technology in Pre-Clinical Setting”

InMed Pharmaceuticals’ (NASDAQ: INM) subsidiary BayMedica is positioned amid a growing interest in edibles infused with non-intoxicating minor cannabinoids. These lesser-known cannabinoids offer unique properties and potential health benefits, driving significant market growth. The company published a report on the expansion of the minor cannabinoid market in 2023. “The report, based on data from Headset, … Continue reading “CannabisNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) BayMedica Poised as Rare Cannabinoids Drive Market Growth”

The Alt Pro Expo, presented by Trinity Hemp, is coming to Atlanta on Oct. 10-12, 2024. Atlanta has a vibrant history with a legacy of smoke-shop culture. The southern city attracts retailers and buyers from neighboring cities, blending seamlessly into the new-age Alternative Products scene. Atlanta offers several recreational options to the attendees of the … Continue reading “Alternative Products Expo Arrives in Atlanta”

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced its 4-week and 8-week blood glucose results from its WEIGHT-A24-1 animal study (the “study”). This study will examine diabetes and weight loss effects of DehydraTECH-processed GLP-1 drugs and DehydraTECH-processed cannabidiol, alone and in combination . The ongoing study uses diabetic, pre-conditioned Zucker … Continue reading “Lexaria Bioscience Corp. (NASDAQ: LEXX) Yields “Extremely Interesting” Results for DehydraTECH(TM) Liraglutide in Ongoing Diabetes Animal Study”

InMed Pharmaceuticals (NASDAQ: INM), a clinical stage pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates targeting the CB1/CB2 receptors, announced that its drug candidate INM-901 as an oral formulation will be used in its development programs for Alzheimer’s disease following encouraging results obtained in preclinical trials (https://cnw.fm/zslQY). INM-901 is a … Continue reading “InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-901: A Promising New Candidate for Alzheimer’s Therapy”

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just released findings from its applied research program that sought to evaluate the mode of action facets of its patented DehydraTECH(TM) technology and the glucagon-like peptide 1 (“GLP-1”) drug, semaglutide. The program was conducted in conjunction with the National Research Council of Canada (“NRC”), … Continue reading “Lexaria Bioscience Corp. (NASDAQ: LEXX) Validates Technology’s Superiority, Moving Closer to a Share in the Global Diabetes Treatment Market”

InMed Pharmaceuticals (NASDAQ: INM), a biopharmaceutical company focused on developing proprietary small molecule drug candidates for diseases with high unmet needs, has announced promising outcomes from a long-term preclinical study of its Alzheimer’s Disease (“AD”) drug candidate, INM-901. These new findings confirm and expand upon results from a previous short-term pilot study (https://cnw.fm/KCFDW). The long-term … Continue reading “InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Promising Long-Term Results for Alzheimer’s Drug INM-901”

Governor Gavin Newsom of California is working toward regulating intoxicating products derived from hemp, via the state Department of Cannabis Control. The governor is actively looking into ways to increase enforcement, close loopholes and prevent underage kids from having access to unsafe marijuana and hemp products. In a recent statement, Gov. Newsom argued that these … Continue reading “Ongoing Battle in California Symbolizes the Longstanding Struggle Between Marijuana and Hemp”

Data from the United States shows that 54% of adults and 66% of children consume more added sugars than recommended (https://cnw.fm/JNFjW). On average, it has been noted that adults, young adults, and children in the United States consume 17 teaspoons of added sugar daily, which is more than two to three times the recommended amount … Continue reading “Lexaria Bioscience Corp. (NASDAQ: LEXX) Targeting Oral GLP-1 Alternatives for Diabetes and Obesity Treatment”

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just released its fiscal report for the third quarter of the 2024 financial year (“Q3, 2024”). Of note was growth in cash and marketable securities from $1.5 million during the same period in the 2023 financial year to $8.5 million as of May 31, … Continue reading “Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Q3 2024 Financial Results; Offers a Roadmap for its Key GLP-1 Study Program”

The U.S. Internal Revenue Service (IRS) intends to continue seeking tax payments from cannabis businesses that have taken deductions in anticipation of possible federal changes, according to an attorney with the agency. Even if marijuana is rescheduled federally, the IRS could theoretically seize assets from marijuana companies that fail to meet their tax obligations. Luke … Continue reading “420 with CNW — IRS to Keep Applying 280E Until Marijuana Reclassification Completed”

Delaware, Ohio, has put a temporary pause on recreational cannabis businesses operating within its city limits; the city council voted 5 to 2 to enforce a six-month moratorium. This decision halts recreational marijuana businesses from opening in the city, giving officials time to consider how to best regulate them. The move follows the approval of … Continue reading “420 with CNW — Delaware, Ohio Temporarily Ban Adult-Use Marijuana Businesses”

A recent federally funded study published in the “Journal of the American Medical Association (JAMA) Network Open” has revealed that cognitive functions such as inhibitory control, reward response and working memory do not change significantly after a year of cannabis use. The study refutes the long-held notion that marijuana use impairs memory and brain function. … Continue reading “420 with CNW — AMA Study Finds Working Memory, Other Brain Processes Unaffected by Cannabis Use”

Marijuana leaders need to use sound financial techniques when operating in the cannabis sector. Given the complexities of the space, companies must devise strategies such as establishing relationships with field experts and looking for fresh revenue streams to differentiate themselves and remain competitive. Here are five crucial financial pointers for marijuana company owners: Focus on … Continue reading “420 with CNW — FIVE Ways to Keep Finances Healthy in Marijuana Industry”

Cannabis industry leaders in Washington State are contemplating the implications of reclassification for researchers and local customers. President Joe Biden disclosed in May that the U.S. Department of Justice (DoJ) was considering a substantial change to the classification of cannabis. The U.S. Drug Enforcement Administration (DEA) currently classifies marijuana as a schedule I substance, classing … Continue reading “420 with CNW — Washington State Marijuana Industry Readies for Change as Feds Mull Reclassification”

A recent study involving hundreds of individuals using medical cannabis has shown significant and rapid improvements in overall health during the first three months of use, according to research from the Philadelphia College of Osteopathic Medicine (PCOM). The findings, published in the “Cannabis Research Journal,” followed almost 400 adults in Pennsylvania who were new to … Continue reading “420 with CNW — Study Shows Users of Medical Cannabis Report Short-Term Benefits in Quality of Life”

Last month, Ohio kicked off its recreational cannabis sales, raising questions about how this would impact Michigan’s already thriving industry, which attracts many Ohio customers. Michigan had become a popular destination for Ohio residents seeking cannabis, with many dispensaries conveniently located near the state border in cities such as Morenci and Monroe. Ohio’s dispensaries sold … Continue reading “420 with CNW — Michigan Cannabis Sales Boom as Recreational Sales Begin in Ohio”

Efforts to legalize medical cannabis in Nebraska have officially been approved for the November election, despite a lawsuit and a statewide review of the validity of collected signatures. Bob Evnen, the secretary of state, announced on Sept. 14, 2024, that the group Nebraskans for Medical Marijuana had gathered an estimated 90,000 legitimate signatures. The announcement … Continue reading “420 with CNW — Nebraska Certifies Ballot Measures to Legalize Medical Cannabis”

Related Editorial While the huge increase in U.S. consumer demand from hemp extracts and hemp product is largely credited as the reason for the boom in the number of hemp acres under cultivation, there is a significant additional part of the hemp-growth story to tell. With a pending acquisition in the cultivation supply market, Sugarmade … Continue reading “CannabisNewsAudio – Sugarmade, Inc. (SGMD) Poised to Profit as Hemp Demand Surges”

Related Editorial The surging hemp industry means exciting benefits for Kentucky. Hemp is big business in Kentucky. Among the companies working in the state is Sugarmade Inc. (OTCQB: SGMD) (SGMD Profile), a supplier of hydroponic equipment that is now moving into hemp through an investment in Hempistry. In New York, a leading politician has been … Continue reading “CannabisNewsAudio – Sugarmade, Inc. (SGMD) Investing in Kentucky’s Hemp Sector”

Related Editorial In between growers and sellers lie several potential places for companies with expertise to firmly establish themselves in the burgeoning cannabis space. Savvy companies such as Youngevity International Inc. (NASDAQ: YGYI) (YGYI Profile) recognize the potential payoff of being involved in the back end of the cannabis industry. The company’s wholly owned subsidiary … Continue reading “CannabisNewsAudio – Youngevity International, Inc. (NASDAQ: YGYI) Expands Reach in Cannabis Industry to Include Processing, Manufacturing”

Related Editorial As hemp production increases, Californian legislators have extended the duration of thousands of cannabis cultivation licenses to support the state’s thriving industry. Sugarmade Inc. (OTCQB: SGMD) (SGMD Profile) is supporting many of these companies that have cultivation licenses by providing cultivation and extraction equipment. Canopy Growth Corporation (TSX: WEED) (NYSE: CGC), one of … Continue reading “CannabisNewsAudio – Sugarmade, Inc. (SGMD) Providing Cultivation, Extraction Equipment as California Hemp Market Surges”

Related Editorial Mainstream retailers across the United States are embracing the growing popularity of the nonpsychoactive cannabinoid, cannabidiol (CBD), making room for CBD products on their prominent shelves. With the rise of these cannabis beauty products, major stores from luxury retailers Barney’s and Neiman Marcus down to Walgreens, Rite Aid and now Kroger are stocking … Continue reading “CannabisNewsAudio – Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) Secures Series of Noteworthy Deals with Top Retailers”

Related Editorial With demand outstripping supply, successful cannabis companies are following smart core strategies and reporting strong revenues. Golden Developing Solutions Inc. (OTC: DVLP) (DVLP Profile) has used a mix of acquisitions, diverse brands and products, and increased production footprint to meet customer demand and report significant revenue increases, including its strongest second-quarter numbers ever. … Continue reading “CannabisNewsAudio – Golden Developing Solutions Inc. (DVLP) Experiencing Strong Growth as Demand Rises in Booming Cannabis Sector”

Related Editorial Rising hemp production is putting pressure on processing. Sugarmade Inc. (OTCQB: SGMD) (SGMD Profile), a provider of cultivation equipment, is adding processors to its catalog of products, focusing on next-generation machinery. Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) will be among the companies with a rising demand for processing, as it increases both … Continue reading “CannabisNewsAudio – Sugarmade, Inc. (SGMD) Exploring the New Generation of Hemp Processing Technology”

Related Editorial The cannabis sector continues its steady shift toward big business, big money and a focus on the value add of immaterial assets. TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8) (TCAN Profile) has made several key acquisitions, creating a large operation with various licenses and recognized brands. HEXO Corp. (TSX: HEXO) (NYSE American: HEXO) … Continue reading “CannabisNewsAudio – TransCanna Holdings Inc. (CSE: TCAN) Flourishing in the Evolving Cannabis Sector through Key Acquisitions”